These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28506261)

  • 1. A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation.
    Fukatsu M; Murakami T; Ohkawara H; Saito S; Ikeda K; Kadowaki S; Sasaki I; Segawa M; Soeda T; Hoshi A; Takahashi H; Shichishima-Nakamura A; Ogawa K; Sugiura Y; Ohto H; Takeishi Y; Ikezoe T; Ugawa Y
    BMC Neurol; 2017 May; 17(1):93. PubMed ID: 28506261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis].
    Yanagihara C; Nakaji K; Tanaka Y; Yabe H; Nishimura Y
    Rinsho Shinkeigaku; 2001 Aug; 41(8):503-6. PubMed ID: 11889835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis after allogeneic bone marrow transplantation.
    Shimoda K; Gondo H; Harada M; Sano T; Nakamura M; Otsuka T; Okamura S; Niho Y
    Bone Marrow Transplant; 1994 Jul; 14(1):155-6. PubMed ID: 7951105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.
    Mackey JR; Desai S; Larratt L; Cwik V; Nabholtz JM
    Bone Marrow Transplant; 1997 May; 19(9):939-42. PubMed ID: 9156270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease.
    Bolger GB; Sullivan KM; Spence AM; Appelbaum FR; Johnston R; Sanders JE; Deeg HJ; Witherspoon RP; Doney KC; Nims J
    Neurology; 1986 Aug; 36(8):1087-91. PubMed ID: 3526178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
    Baron F; Sadzot B; Wang F; Beguin Y
    Bone Marrow Transplant; 1998 Jul; 22(2):197-200. PubMed ID: 9707030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation.
    Heidarzadeh Z; Mousavi SA; Ostovan VR; Nafissi S
    Neuromuscul Disord; 2014 Feb; 24(2):148-50. PubMed ID: 24314584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of bone marrow-derived mesenchymal stem cells in reduction of graft-versus-host disease by effecting CD4+CD25+ regulatory T cells in rats].
    Tian Y; Deng YB; Huang YJ; Na XD; Li Y; Ye MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1210-4. PubMed ID: 17204196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report.
    Sossa Melo CL; Peña AM; Salazar LA; Jiménez SI; Gómez ED; Chalela CM; Ayala-Castillo M; Peña IM
    Neuromuscul Disord; 2019 Feb; 29(2):142-145. PubMed ID: 30639064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature.
    Zaja F; Barillari G; Russo D; Silvestri F; Fanin R; Baccarani M
    Acta Neurol Scand; 1997 Oct; 96(4):256-9. PubMed ID: 9325479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Durable remission attained with plasmapheresis and intravenous immunoglobulin therapy in a patient with acute exacerbation of GVHD-related myasthenia gravis].
    Nakashima J; Itonaga H; Fujioka M; Chiwata M; Sawayama Y; Yoshimura S; Iwanaga H; Taguchi J; Yoshida S; Miyazaki Y
    Rinsho Ketsueki; 2018; 59(5):480-484. PubMed ID: 29877233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
    Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
    Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.
    Strober J; Cowan MJ; Horn BN
    Arch Neurol; 2009 May; 66(5):659-61. PubMed ID: 19433668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review.
    Tsutsumi Y; Kamiishi T; Kikuchi R; Ito S; Matsuoka S; Teshima T
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):110-114. PubMed ID: 28549768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab].
    Hayashi R; Tahara M; Oeda T; Konishi T; Sawada H
    Rinsho Shinkeigaku; 2015; 55(4):227-32. PubMed ID: 25904250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
    Sakuma H; Katayama A; Saito Y; Komaki H; Nakagawa E; Sugai K; Sasaki M
    Brain Dev; 2011 May; 33(5):442-4. PubMed ID: 20797828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis.
    Nishimura T; Inaba Y; Nakazawa Y; Omata T; Akasaka M; Shirai I; Ichikawa M
    Brain Dev; 2015 Sep; 37(8):808-16. PubMed ID: 25563663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.